{"name":"Hôpital le Vinatier","slug":"h-pital-le-vinatier","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cannabidiol oral oil","genericName":"Cannabidiol oral oil","slug":"cannabidiol-oral-oil","indication":"Seizure disorders (Dravet syndrome, Lennox-Gastaut syndrome)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Placebo oral oil","genericName":"Placebo oral oil","slug":"placebo-oral-oil","indication":"Clinical trial control arm (therapeutic area unknown)","status":"phase_3"}]}],"pipeline":[{"name":"Cannabidiol oral oil","genericName":"Cannabidiol oral oil","slug":"cannabidiol-oral-oil","phase":"marketed","mechanism":"Cannabidiol modulates endocannabinoid signaling and multiple other pathways to produce anxiolytic, anti-inflammatory, and neuroprotective effects.","indications":["Seizure disorders (Dravet syndrome, Lennox-Gastaut syndrome)","Anxiety disorders","Epilepsy"],"catalyst":""},{"name":"Placebo oral oil","genericName":"Placebo oral oil","slug":"placebo-oral-oil","phase":"phase_3","mechanism":"Placebo oral oil produces no pharmacological effect, serving as an inert control in clinical trials.","indications":["Clinical trial control arm (therapeutic area unknown)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}